Loading…
Reported covered position: Sr. Counsel House Energy&Commerce Cmte 98-08
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Preserving Access to Life-Saving Medications Act of 2011
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Implementation of Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act H.R. 2245 / S. 296, Preserving Access to Life-Saving Medications Act of 2011 H.R. 5, Protecting Access to Healthcare Act of 2012 H.R. 3497, The MODDERN Cures Act of 2011 H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011 Reauthorization of The Prescription Drug User Fee Act Reauthorization of the Medical Device User Fee Act Policies for FDA product approval reform Proposals to improve viral hepatitis screening and testing
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: ABBOTT LABORATORIES · Firm:
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2012 · fourth_quarter · Q4
Public Law 111-148, The Patient Protection and Affordable Care Act Public Law 111-152, The Reconciliation Act of 2010 Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act H.R. 3497, MODDERN Cures Act of 2011 H.R.6446, To create incentive for innovative diagnostics by improving the process for determining Medicare payment rates for new tests Proposals to increase security of US drug distribution supply chain Proposals to improve viral hepatitis screening and testing Policies for FDA product approval reform
Public Law 112-208, The Russia and Moldova Jackson-Vanik Repeal Act of 2012 Trade issues regarding the Trans-Pacific Partnership Agreement
Source: Senate LDA
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Implementation of Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act H.R. 2245 / S. 296, Preserving Access to Life-Saving Medications Act of 2011 H.R. 5, Protecting Access to Healthcare Act of 2012 H.R. 3497, The MODDERN Cures Act of 2011 H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011 Reauthorization of The Prescription Drug User Fee Act Reauthorization of the Medical Device User Fee Act Policies for FDA product approval reform Proposals to improve viral hepatitis screening and testing
Public Law 111-148, The Patient Protection and Affordable Care Act Public Law 111-152, The Reconciliation Act of 2010 Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act H.R. 3497, MODDERN Cures Act of 2011 H.R.6446, To create incentive for innovative diagnostics by improving the process for determining Medicare payment rates for new tests Proposals to increase security of US drug distribution supply chain Proposals to improve viral hepatitis screening and testing Policies for FDA product approval reform
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Implementation of Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act H.R. 2245 / S. 296, Preserving Access to Life-Saving Medications Act of 2011 H.R. 5, Protecting Access to Healthcare Act of 2012 H.R. 3497, The MODDERN Cures Act of 2011 H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011 Reauthorization of The Prescription Drug User Fee Act Reauthorization of the Medical Device User Fee Act Policies for FDA product approval reform Proposals to improve viral hepatitis screening and testing
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act Implemenation of S.3187, The Food and Drug Administration Safety and Innovation Act of 2012 S.27 Preserve Access to Affordable Generics Act H.R. 3497, The MODDERN Cures Act of 2011 H.R.6446, a bill to create incentive for innovative diagnostics by improving the process for determining Medicare payment rates for new tests Proposals to establish a system to improve pharmaceutical traceability
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act Implemenation of S.3187, The Food and Drug Administration Safety and Innovation Act of 2012 S.27 Preserve Access to Affordable Generics Act H.R. 3497, The MODDERN Cures Act of 2011 H.R.6446, a bill to create incentive for innovative diagnostics by improving the process for determining Medicare payment rates for new tests Proposals to establish a system to improve pharmaceutical traceability
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Implementation of Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act S.3187, the Food and Drug Administration Safety and Innovation Act of 2012 H.R. 3497, The MODDERN Cures Act of 2011 Funding for State AIDS Drug Assistance programs under Ryan White Care Act
Improving Diagnostic Innovations Act of 2012
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Public Law 111-148, The Patient Protection and Affordable Care Act Public Law 111-152, The Reconciliation Act of 2010 Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act H.R. 3497, MODDERN Cures Act of 2011 H.R.6446, To create incentive for innovative diagnostics by improving the process for determining Medicare payment rates for new tests Proposals to increase security of US drug distribution supply chain Proposals to improve viral hepatitis screening and testing Policies for FDA product approval reform
Improving Diagnostic Innovations Act of 2012
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act Implemenation of S.3187, The Food and Drug Administration Safety and Innovation Act of 2012 S.27 Preserve Access to Affordable Generics Act H.R. 3497, The MODDERN Cures Act of 2011 H.R.6446, a bill to create incentive for innovative diagnostics by improving the process for determining Medicare payment rates for new tests Proposals to establish a system to improve pharmaceutical traceability
Improving Diagnostic Innovations Act of 2012
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act Implemenation of S.3187, The Food and Drug Administration Safety and Innovation Act of 2012 S.27 Preserve Access to Affordable Generics Act H.R. 3497, The MODDERN Cures Act of 2011 H.R.6446, a bill to create incentive for innovative diagnostics by improving the process for determining Medicare payment rates for new tests Proposals to establish a system to improve pharmaceutical traceability
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Implementation of Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act S.319, The Pharmaceutical Market Access and Drug Safety Act of 2011 Reauthorization of The Prescription Drug User Fee Act Reauthorization of The Medical Device User Fee Act H.R.5440, Genomics and Personalized Medicine Act of 2010 H.R. 1483, Drug Safety Enhancement Act of 2011 Proposals to reduce health disparities Policies for FDA product approval reform FDA proposals to enhance imported product safety Briefings on medical device techonology
S.17, Medical Device Access and Innovation Protection Act H.R.675, Strengthening Medicare Anti-Fraud Measures Act of 2011 H.R.2190, Medicare Drug Savings Act of 2011 S.1206, Medicare Drug Savings Act of 2011
Preserving Access to Life-Saving Medications Act of 2011
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 H.R. 2245 / S. 296, Preserving Access to Life-Saving Medications Act of 2011 S. 27, Preserve Access to Affordable Generics Act H.R. 3026, Safeguarding Americas Pharmaceuticals Act of 2011 H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Amendment #769 Reauthorization of The Prescription Drug User Fee Act Reauthorization of the Medical Device User Fee Act Policies for FDA product approval reform FDA proposals to enhance imported product safety
Preserving Access to Life-Saving Medications Act of 2011
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Implementation of Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act S.319, the Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.2245, Preserving Access to Life-Saving Medications Act of 2011 S.296, Preserving Access to Life-Saving Medications Act of 2011 Reauthorization of The Prescription Drug User Fee Act Reauthorization of The Medical Device User Fee Act Proposals to expand debt ceiling, various proposals related to health care Proposals to advance personalized medicine Proposals to improve viral hepatitis screening and testing Policies for FDA product approval reform Briefings on medical device technology
Safeguarding America's Pharmaceuticals Act of 2011
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 H.R. 2245 / S. 296, Preserving Access to Life-Saving Medications Act of 2011 S. 27, Preserve Access to Affordable Generics Act H.R. 3026, Safeguarding Americas Pharmaceuticals Act of 2011 H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Amendment #769 Reauthorization of The Prescription Drug User Fee Act Reauthorization of the Medical Device User Fee Act Policies for FDA product approval reform FDA proposals to enhance imported product safety
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 110-275, Medicare DMEPOS Competitive Acquistion Program Proposals to expand competitive bidding for DMEPOS H.R. 675, Strenghten Medicare Anti-Fraud Measures Act of 2011 H.R. 3497, The MODDERN Cures Act of 2011 H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011 Proposals to give the Centers for Medicare and Medicaid authority to use the least costly alternative reimbursement policy Policies to enhance patient access to medicines in Medicare Reimbursement protocols for HIV diagnostics Medciare payment proposals
Implementation of Public Law 110-275, Medicare DMEPOS Competitive Acquistion Program Proposals to expand competitive bidding for DMEPOS H.R. 675, Strenghten Medicare Anti-Fraud Measures Act of 2011 H.R. 3497, The MODDERN Cures Act of 2011 H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011 Proposals to give the Centers for Medicare and Medicaid authority to use the least costly alternative reimbursement policy Policies to enhance patient access to medicines in Medicare Reimbursement protocols for HIV diagnostics Medciare payment proposals
Strengthening Medicare Anti-Fraud Measures Act of 2011
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 110-275, Medicare DMEPOS Competitive Acquistion Program Proposals to expand competitive bidding for DMEPOS H.R. 675, Strenghten Medicare Anti-Fraud Measures Act of 2011 H.R. 3497, The MODDERN Cures Act of 2011 H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011 Proposals to give the Centers for Medicare and Medicaid authority to use the least costly alternative reimbursement policy Policies to enhance patient access to medicines in Medicare Reimbursement protocols for HIV diagnostics Medciare payment proposals
Strengthening Medicare Anti-Fraud Measures Act of 2011
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 110-275 Medicare DMEPOS Competative Acquistion Program Proposals to expand competitive bidding for DMEPOS S.17, Medical Device Access and Innovation Protection Act H.R.675 Strengthening Medicare Anti-Fraud Measures Act of 2011 Medicare Part D program
Strengthening Medicare Anti-Fraud Measures Act of 2011
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 110-275 Medicare DMEPOS Competitive Acquistion Program Proposals to expand competitive bidding for DMEPOS S.17, Medical Device Access and Innovation Protection Act H.R. 675, Strengthening Medicare Anti-Fraud Measures Act of 2011 Proposals to give Center for Medicare and Medicaid Services authority to use the least costly alternative reimbursement policy Policies to enhance patient access to medicines in Medicare Reimbursement protocols for HIV diagnostics Medicare payment proposals
Strengthening Medicare Anti-Fraud Measures Act of 2011
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S.17, Medical Device Access and Innovation Protection Act H.R.675, Strengthening Medicare Anti-Fraud Measures Act of 2011 H.R.2190, Medicare Drug Savings Act of 2011 S.1206, Medicare Drug Savings Act of 2011
Genomics and Personalized Medicine Act of 2010
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Implementation of Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act S.319, The Pharmaceutical Market Access and Drug Safety Act of 2011 Reauthorization of The Prescription Drug User Fee Act Reauthorization of The Medical Device User Fee Act H.R.5440, Genomics and Personalized Medicine Act of 2010 H.R. 1483, Drug Safety Enhancement Act of 2011 Proposals to reduce health disparities Policies for FDA product approval reform FDA proposals to enhance imported product safety Briefings on medical device techonology
District of Columbia Hatch Act Reform Act of 2010
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Health Care Reform Implementation H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010 Proposals to address reimbursement of diagnostics Reauthorization of The Prescription Drug User Fee Act (PDUFA) Reauthorization of The Medical Device User Fee Act (MDUFA) Biodefense and pandemic preparedness H.R. 1345/S.540 Medical Device Safety Act of 2009 Policies for FDA product approval process Briefings on eye care
District of Columbia Hatch Act Reform Act of 2010
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Health Care Reform Implementation H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010 Proposals to address reimbursement of diagnostics Reauthorization of The Prescription Drug User Fee Act (PDUFA) Reauthorization of The Medical Device User Fee Act (MDUFA) Biodefense and pandemic preparedness H.R. 1345/S.540 Medical Device Safety Act of 2009 Policies for FDA product approval process Briefings on eye care
Health Care Reform H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act HR 3200: America's Affordable Health Choices Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Health Care Reform Implementation H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010 Proposals to address reimbursement of diagnostics Reauthorization of The Prescription Drug User Fee Act (PDUFA) Reauthorization of The Medical Device User Fee Act (MDUFA) Biodefense and pandemic preparedness H.R. 1345/S.540 Medical Device Safety Act of 2009 Policies for FDA product approval process Briefings on eye care
Health Care Reform Implementation H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010 Proposals to address reimbursement of diagnostics Reauthorization of The Prescription Drug User Fee Act (PDUFA) Reauthorization of The Medical Device User Fee Act (MDUFA) Biodefense and pandemic preparedness H.R. 1345/S.540 Medical Device Safety Act of 2009 Policies for FDA product approval process Briefings on eye care
Health Care Reform H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act HR 3200: America's Affordable Health Choices Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009 S.2766 Medical Foods Equity Act of 2009
S. 510 Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009 S.2766 Medical Foods Equity Act of 2009
S. 510 FDA Food Safety Modernization Act H.R.2749 Food Safety Enhancement Act of 2009
America's Affordable Health Choices Act of 2009
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Health Care Reform H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act HR 3200: America's Affordable Health Choices Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
America's Affordable Health Choices Act of 2009
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Health Care Reform H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act HR 3200: America's Affordable Health Choices Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Improving Nutrition for America's Children Act
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Special Supplemental Nutrition Program for Women, Infants and Children (WIC) Reauthorization S. 3307 Healthy, Hunger-Free Kids Act of 2010 H.R. 5504 Improving Nutrition for America's Children Act
Improving Nutrition for America's Children Act
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Special Supplemental Nutrition Program for Women, Infants and Children (WIC) Reauthorization S. 3307 Healthy, Hunger-Free Kids Act of 2010 H.R. 5504 Improving Nutrition for America's Children Act
Improving Nutrition for America's Children Act
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 3307 Healthy, Hunger-Free Kids Act of 2010 H.R. 5504 Improving Nutrition for America's Children Act Special Supplemental Nutrition Program for Women, Infants and Children (WIC) procedures Initiatives regarding infant nutrition
Food and Drug Administration Globalization Act of 2009
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 S. 3397 Secure and Responsible Drug Disposal Act of 2010 H.R.759 Food and Drug Administration Globalization Act of 2009 Reauthorization of the Prescription Drug User Fee Act (PDUFA) Reauthorization of the Medical Device User Fee Act (MDUFA) Proposals to address reimbursement of diagnostics
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009 S.2766 Medical Foods Equity Act of 2009
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009 S.2766 Medical Foods Equity Act of 2009
Secure and Responsible Drug Disposal Act of 2010
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 S. 3397 Secure and Responsible Drug Disposal Act of 2010 H.R.759 Food and Drug Administration Globalization Act of 2009 Reauthorization of the Prescription Drug User Fee Act (PDUFA) Reauthorization of the Medical Device User Fee Act (MDUFA) Proposals to address reimbursement of diagnostics
Health Care Reform Implementation H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010 Proposals to address reimbursement of diagnostics Reauthorization of The Prescription Drug User Fee Act (PDUFA) Reauthorization of The Medical Device User Fee Act (MDUFA) Biodefense and pandemic preparedness H.R. 1345/S.540 Medical Device Safety Act of 2009 Policies for FDA product approval process Briefings on eye care
Health Care Reform Implementation H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010 Proposals to address reimbursement of diagnostics Reauthorization of The Prescription Drug User Fee Act (PDUFA) Reauthorization of The Medical Device User Fee Act (MDUFA) Biodefense and pandemic preparedness H.R. 1345/S.540 Medical Device Safety Act of 2009 Policies for FDA product approval process Briefings on eye care
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009 S.2766 Medical Foods Equity Act of 2009
S. 510 FDA Food Safety Modernization Act H.R.2749 Food Safety Enhancement Act of 2009
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009 S.2766 Medical Foods Equity Act of 2009
S. 510 Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Health Care Reform H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act HR 3200: America's Affordable Health Choices Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Health Care Reform H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act HR 3200: America's Affordable Health Choices Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Health Care Reform Implementation H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010 Proposals to address reimbursement of diagnostics Reauthorization of The Prescription Drug User Fee Act (PDUFA) Reauthorization of The Medical Device User Fee Act (MDUFA) Biodefense and pandemic preparedness H.R. 1345/S.540 Medical Device Safety Act of 2009 Policies for FDA product approval process Briefings on eye care
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Health Care Reform Implementation H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010 Proposals to address reimbursement of diagnostics Reauthorization of The Prescription Drug User Fee Act (PDUFA) Reauthorization of The Medical Device User Fee Act (MDUFA) Biodefense and pandemic preparedness H.R. 1345/S.540 Medical Device Safety Act of 2009 Policies for FDA product approval process Briefings on eye care
Health Care Reform Implementation H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010 Proposals to address reimbursement of diagnostics Reauthorization of The Prescription Drug User Fee Act (PDUFA) Reauthorization of The Medical Device User Fee Act (MDUFA) Biodefense and pandemic preparedness H.R. 1345/S.540 Medical Device Safety Act of 2009 Policies for FDA product approval process Briefings on eye care
Health Care Reform Implementation H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010 Proposals to address reimbursement of diagnostics Reauthorization of The Prescription Drug User Fee Act (PDUFA) Reauthorization of The Medical Device User Fee Act (MDUFA) Biodefense and pandemic preparedness H.R. 1345/S.540 Medical Device Safety Act of 2009 Policies for FDA product approval process Briefings on eye care
American Middle Class Tax (AMT) Relief Act of 2007
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Health Care Reform Implementation H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010 Proposals to address reimbursement of diagnostics Reauthorization of The Prescription Drug User Fee Act (PDUFA) Reauthorization of The Medical Device User Fee Act (MDUFA) Biodefense and pandemic preparedness H.R. 1345/S.540 Medical Device Safety Act of 2009 Policies for FDA product approval process Briefings on eye care
American Middle Class Tax (AMT) Relief Act of 2007
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Health Care Reform H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act HR 3200: America's Affordable Health Choices Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
American Middle Class Tax (AMT) Relief Act of 2007
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Health Care Reform H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act HR 3200: America's Affordable Health Choices Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
American Middle Class Tax (AMT) Relief Act of 2007
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Health Care Reform Implementation H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010 Proposals to address reimbursement of diagnostics Reauthorization of The Prescription Drug User Fee Act (PDUFA) Reauthorization of The Medical Device User Fee Act (MDUFA) Biodefense and pandemic preparedness H.R. 1345/S.540 Medical Device Safety Act of 2009 Policies for FDA product approval process Briefings on eye care
Medicare Improvements for Patients and Providers Act of 2008
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 6331/S. 3101 Medicare Improvements for Patients and Providers Act of 2008, implementation of sections 153, 154
Medicare Improvements for Patients and Providers Act of 2008
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 6331/S. 3101 Medicare Improvements for Patients and Providers Act of 2008, implementation of sections 153, 154
Medicare Improvements for Patients and Providers Act of 2008
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 6331/S. 3101 Medicare Improvements for Patients and Providers Act of 2008, implementation of sections 153, 154
Medicare Improvements for Patients and Providers Act of 2008
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 6331/S. 3101 Medicare Improvements for Patients and Providers Act of 2008, implementation of sections 153, 154
Health Care Reform S 1679: Affordable Health Choices Act S 1796: America's Healthy Future Act HR 3200: America's Affordable Health Choices Act H.R. 3962 Affordable Health Care for America Act H.R. 1548 Pathway for Biosimilars Act H.R.1346/S.540 Medical Device Safety Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Health Care Reform S 1679: Affordable Health Choices Act S 1796: America's Healthy Future Act HR 3200: America's Affordable Health Choices Act H.R. 3962 Affordable Health Care for America Act H.R. 1548 Pathway for Biosimilars Act H.R.1346/S.540 Medical Device Safety Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Health Care Reform S 1679: Affordable Health Choices Act S 1796: America's Healthy Future Act HR 3200: America's Affordable Health Choices Act H.R. 3962 Affordable Health Care for America Act H.R. 1548 Pathway for Biosimilars Act H.R.1346/S.540 Medical Device Safety Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Health Care Reform S 1679: Affordable Health Choices Act S 1796: America's Healthy Future Act HR 3200: America's Affordable Health Choices Act H.R. 3962 Affordable Health Care for America Act H.R. 1548 Pathway for Biosimilars Act H.R.1346/S.540 Medical Device Safety Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
America's Affordable Health Choices Act of 2009
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Health Care Reform S 1679: Affordable Health Choices Act S 1796: America's Healthy Future Act HR 3200: America's Affordable Health Choices Act H.R. 3962 Affordable Health Care for America Act H.R. 1548 Pathway for Biosimilars Act H.R.1346/S.540 Medical Device Safety Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
America's Affordable Health Choices Act of 2009
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Health Care Reform S 1679: Affordable Health Choices Act S 1796: America's Healthy Future Act HR 3200: America's Affordable Health Choices Act H.R. 3962 Affordable Health Care for America Act H.R. 1548 Pathway for Biosimilars Act H.R.1346/S.540 Medical Device Safety Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Health Care Reform S 1679: Affordable Health Choices Act S 1796: America's Healthy Future Act HR 3200: America's Affordable Health Choices Act H.R. 3962 Affordable Health Care for America Act H.R. 1548 Pathway for Biosimilars Act H.R.1346/S.540 Medical Device Safety Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Health Care Reform S 1679: Affordable Health Choices Act S 1796: America's Healthy Future Act HR 3200: America's Affordable Health Choices Act H.R. 3962 Affordable Health Care for America Act H.R. 1548 Pathway for Biosimilars Act H.R.1346/S.540 Medical Device Safety Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Health Care Reform S 1679: Affordable Health Choices Act S 1796: America's Healthy Future Act HR 3200: America's Affordable Health Choices Act H.R. 3962 Affordable Health Care for America Act H.R. 1548 Pathway for Biosimilars Act H.R.1346/S.540 Medical Device Safety Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Health Care Reform S 1679: Affordable Health Choices Act S 1796: America's Healthy Future Act HR 3200: America's Affordable Health Choices Act H.R. 3962 Affordable Health Care for America Act H.R. 1548 Pathway for Biosimilars Act H.R.1346/S.540 Medical Device Safety Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Health Care Reform S 1679: Affordable Health Choices Act S 1796: America's Healthy Future Act HR 3200: America's Affordable Health Choices Act H.R. 3962 Affordable Health Care for America Act H.R. 1548 Pathway for Biosimilars Act H.R.1346/S.540 Medical Device Safety Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Health Care Reform S 1679: Affordable Health Choices Act S 1796: America's Healthy Future Act HR 3200: America's Affordable Health Choices Act H.R. 3962 Affordable Health Care for America Act H.R. 1548 Pathway for Biosimilars Act H.R.1346/S.540 Medical Device Safety Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Health Care Reform S 1679: Affordable Health Choices Act S 1796: America's Healthy Future Act HR 3200: America's Affordable Health Choices Act H.R. 3962 Affordable Health Care for America Act H.R. 1548 Pathway for Biosimilars Act H.R.1346/S.540 Medical Device Safety Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Health Care Reform S 1679: Affordable Health Choices Act S 1796: America's Healthy Future Act HR 3200: America's Affordable Health Choices Act H.R. 3962 Affordable Health Care for America Act H.R. 1548 Pathway for Biosimilars Act H.R.1346/S.540 Medical Device Safety Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
American Middle Class Tax (AMT) Relief Act of 2007
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Health Care Reform S 1679: Affordable Health Choices Act S 1796: America's Healthy Future Act HR 3200: America's Affordable Health Choices Act H.R. 3962 Affordable Health Care for America Act H.R. 1548 Pathway for Biosimilars Act H.R.1346/S.540 Medical Device Safety Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
American Middle Class Tax (AMT) Relief Act of 2007
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Health Care Reform S 1679: Affordable Health Choices Act S 1796: America's Healthy Future Act HR 3200: America's Affordable Health Choices Act H.R. 3962 Affordable Health Care for America Act H.R. 1548 Pathway for Biosimilars Act H.R.1346/S.540 Medical Device Safety Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Health Care Reform S 1679: Affordable Health Choices Act S 1796: America's Healthy Future Act HR 3200: America's Affordable Health Choices Act H.R. 3962 Affordable Health Care for America Act H.R. 1548 Pathway for Biosimilars Act H.R.1346/S.540 Medical Device Safety Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Health Care Reform S 1679: Affordable Health Choices Act S 1796: America's Healthy Future Act HR 3200: America's Affordable Health Choices Act H.R. 3962 Affordable Health Care for America Act H.R. 1548 Pathway for Biosimilars Act H.R.1346/S.540 Medical Device Safety Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2012 · third_quarter · Q3
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act Implemenation of S.3187, The Food and Drug Administration Safety and Innovation Act of 2012 S.27 Preserve Access to Affordable Generics Act H.R. 3497, The MODDERN Cures Act of 2011 H.R.6446, a bill to create incentive for innovative diagnostics by improving the process for determining Medicare payment rates for new tests Proposals to establish a system to improve pharmaceutical traceability
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2012 · second_quarter · Q2
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act Implemenation of S.3187, The Food and Drug Administration Safety and Innovation Act of 2012 S.27 Preserve Access to Affordable Generics Act H.R. 3497, The MODDERN Cures Act of 2011 H.R.6446, a bill to create incentive for innovative diagnostics by improving the process for determining Medicare payment rates for new tests Proposals to establish a system to improve pharmaceutical traceability
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2012 · second_quarter · Q2
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Implementation of Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act S.3187, the Food and Drug Administration Safety and Innovation Act of 2012 H.R. 3497, The MODDERN Cures Act of 2011 Funding for State AIDS Drug Assistance programs under Ryan White Care Act
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2012 · first_quarter · Q1
Implementation of Public Law 110-275, Medicare DMEPOS Competitive Acquistion Program Proposals to expand competitive bidding for DMEPOS Policies to enhance patient access to medicines in Medicare Medciare payment proposals
Initiatives regarding infant nutrition
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Implementation of Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act H.R. 2245 / S. 296, Preserving Access to Life-Saving Medications Act of 2011 H.R. 5, Protecting Access to Healthcare Act of 2012 H.R. 3497, The MODDERN Cures Act of 2011 H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011 Reauthorization of The Prescription Drug User Fee Act Reauthorization of the Medical Device User Fee Act Policies for FDA product approval reform Proposals to improve viral hepatitis screening and testing
Filing targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Securities & Exchange Commission (SEC), U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2011 · fourth_quarter · Q4
Initiatives regarding infant nutrition
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 H.R. 2245 / S. 296, Preserving Access to Life-Saving Medications Act of 2011 S. 27, Preserve Access to Affordable Generics Act H.R. 3026, Safeguarding Americas Pharmaceuticals Act of 2011 H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Amendment #769 Reauthorization of The Prescription Drug User Fee Act Reauthorization of the Medical Device User Fee Act Policies for FDA product approval reform FDA proposals to enhance imported product safety
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2011 · third_quarter · Q3
Implementation of Public Law 110-275 Medicare DMEPOS Competitive Acquistion Program Proposals to expand competitive bidding for DMEPOS S.17, Medical Device Access and Innovation Protection Act H.R. 675, Strengthening Medicare Anti-Fraud Measures Act of 2011 Proposals to give Center for Medicare and Medicaid Services authority to use the least costly alternative reimbursement policy Policies to enhance patient access to medicines in Medicare Reimbursement protocols for HIV diagnostics Medicare payment proposals
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 S.319, The Pharmaceutical Market Access and Drug Safety Act of 2011 Reauthorization of The Prescription Drug User Fee Act of 2010 Reauthorization of The Medical Device User Fee Act of 2010 Policies for FDA product approval reform FDA proposals to enhance imported product safety
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, State, Dept of (DOS)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2011 · second_quarter · Q2
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Implementation of Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act S.319, the Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.2245, Preserving Access to Life-Saving Medications Act of 2011 S.296, Preserving Access to Life-Saving Medications Act of 2011 Reauthorization of The Prescription Drug User Fee Act Reauthorization of The Medical Device User Fee Act Proposals to expand debt ceiling, various proposals related to health care Proposals to advance personalized medicine Proposals to improve viral hepatitis screening and testing Policies for FDA product approval reform Briefings on medical device technology
Proposals to reform domestic and international tax structures
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2011 · first_quarter · Q1
Implementation of Public Law 110-275 Medicare DMEPOS Competative Acquistion Program Proposals to expand competitive bidding for DMEPOS S.17, Medical Device Access and Innovation Protection Act H.R.675 Strengthening Medicare Anti-Fraud Measures Act of 2011 Medicare Part D program
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Implementation of Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act S.319, The Pharmaceutical Market Access and Drug Safety Act of 2011 Reauthorization of The Prescription Drug User Fee Act Reauthorization of The Medical Device User Fee Act H.R.5440, Genomics and Personalized Medicine Act of 2010 H.R. 1483, Drug Safety Enhancement Act of 2011 Proposals to reduce health disparities Policies for FDA product approval reform FDA proposals to enhance imported product safety Briefings on medical device techonology
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), White House Office
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2010 · fourth_quarter · Q4
S. 510 Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2010 · second_quarter · 2A
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009
Health Care Reform Implementation H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010 Proposals to address reimbursement of diagnostics Reauthorization of The Prescription Drug User Fee Act (PDUFA) Reauthorization of The Medical Device User Fee Act (MDUFA) Biodefense and pandemic preparedness H.R. 1345/S.540 Medical Device Safety Act of 2009 Policies for FDA product approval process Briefings on eye care
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2010 · first_quarter · 1A
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009 S.2766 Medical Foods Equity Act of 2009
FY 2011 Budget Biodefense and pandemic preparedness
Health Care Reform H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act HR 3200: America's Affordable Health Choices Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2010 · third_quarter · Q3
Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 S. 3397 Secure and Responsible Drug Disposal Act of 2010 H.R.759 Food and Drug Administration Globalization Act of 2009 Reauthorization of the Prescription Drug User Fee Act (PDUFA) Reauthorization of the Medical Device User Fee Act (MDUFA) Proposals to address reimbursement of diagnostics
S. 510 FDA Food Safety Modernization Act H.R.2749 Food Safety Enhancement Act of 2009
S. 3307 Healthy, Hunger-Free Kids Act of 2010 H.R. 5504 Improving Nutrition for America's Children Act Special Supplemental Nutrition Program for Women, Infants and Children (WIC) procedures Initiatives regarding infant nutrition
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2010 · second_quarter · Q2
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009
Health Care Reform Implementation H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010 Proposals to address reimbursement of diagnostics Reauthorization of The Prescription Drug User Fee Act (PDUFA) Reauthorization of The Medical Device User Fee Act (MDUFA) Biodefense and pandemic preparedness H.R. 1345/S.540 Medical Device Safety Act of 2009 Policies for FDA product approval process Briefings on eye care
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2010 · first_quarter · Q1
Health Care Reform H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act HR 3200: America's Affordable Health Choices Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
FY 2011 Budget Biodefense and pandemic preparedness
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009 S.2766 Medical Foods Equity Act of 2009
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2009 · fourth_quarter · 4A
Health Care Reform S 1679: Affordable Health Choices Act S 1796: America's Healthy Future Act HR 3200: America's Affordable Health Choices Act H.R. 3962 Affordable Health Care for America Act H.R. 1548 Pathway for Biosimilars Act H.R.1346/S.540 Medical Device Safety Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2009 · fourth_quarter · Q4
Health Care Reform S 1679: Affordable Health Choices Act S 1796: America's Healthy Future Act HR 3200: America's Affordable Health Choices Act H.R. 3962 Affordable Health Care for America Act H.R. 1548 Pathway for Biosimilars Act H.R.1346/S.540 Medical Device Safety Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
Proposals to reform domestic and international tax structures R&D Tax Credit, Controlled Foreign Corporation look-through
Implementation of Public Law 110-275, Medicare DMEPOS Competitive Acquistion Program Proposals to expand competitive bidding for DMEPOS H.R. 675, Strenghten Medicare Anti-Fraud Measures Act of 2011 H.R. 3497, The MODDERN Cures Act of 2011 H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011 Proposals to give the Centers for Medicare and Medicaid authority to use the least costly alternative reimbursement policy Policies to enhance patient access to medicines in Medicare Reimbursement protocols for HIV diagnostics Medciare payment proposals
Filing targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Securities & Exchange Commission (SEC), White House Office
S.17, Medical Device Access and Innovation Protection Act H.R.675, Strengthening Medicare Anti-Fraud Measures Act of 2011 H.R.2190, Medicare Drug Savings Act of 2011 S.1206, Medicare Drug Savings Act of 2011
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Securities & Exchange Commission (SEC), White House Office
FY 2011 Budget Biodefense and pandemic preparedness appropriations Funding for state AIDS drug assistance programs under the Ryan White Care Act Appropriations for Food & Drug Administration (FDA) and Centers for Disease Control (CDC)
Special Supplemental Nutrition Program for Women, Infants and Children (WIC) Reauthorization S. 3307 Healthy, Hunger-Free Kids Act of 2010 H.R. 5504 Improving Nutrition for America's Children Act
H.R. 6331/S. 3101 Medicare Improvements for Patients and Providers Act of 2008, implementation of sections 153, 154
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of Management & Budget (OMB), SENATE, Treasury, Dept of
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
FY 2011 Budget Biodefense and pandemic preparedness appropriations Funding for state AIDS drug assistance programs under the Ryan White Care Act Appropriations for Food & Drug Administration (FDA) and Centers for Disease Control (CDC)
H.R. 6331/S. 3101 Medicare Improvements for Patients and Providers Act of 2008, implementation of sections 153, 154
Special Supplemental Nutrition Program for Women, Infants and Children (WIC) Reauthorization S. 3307 Healthy, Hunger-Free Kids Act of 2010 H.R. 5504 Improving Nutrition for America's Children Act
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of Management & Budget (OMB), SENATE, Treasury, Dept of